Worldwide there have been over 760 million confirmed coronavirus disease 2019 (COVID-
19) cases, and over 13 billion COVID-19 vaccine doses have been administered as of April …

Coronavirus disease 2019 (COVID-19) is a viral infection with the novel severe acute
respiratory distress syndrome corona virus 2 (SARS-CoV-2). Until now, more than 670 …

Objectives To better define the spectrum of new-onset post-COVID-19 and post-COVID-19
vaccine inflammatory rheumatic diseases (IRD) from a large multicentric observational …

Background: Development and worldwide availability of safe and effective vaccines against
severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) to fight severe symptoms of …

Introduction Since its emergence, there have been huge efforts to design vaccines against
coronavirus disease 2019 (COVID-19) to inhibit its interpersonal spread. Global vaccine …

Vaccine-induced immune thrombotic thrombocytopenia (VITT), also known as thrombosis
with thrombocytopenia syndrome, is a catastrophic and life-threatening reaction to …

For the development of new adenovirus (AdV)-based vectors, it is important to understand
differences in immunogenicity. In a side-by-side in vitro analysis, we evaluated the effect of …

Background The fight against COVID-19 requires mass vaccination strategies, and vaccines
inducing durable cross-protective responses are still needed. Inactivated vaccines have …

Introduction: Cerebral venous sinus thrombosis associated with vaccine-induced immune
thrombotic thrombocytopenia (CVST-VITT) is a severe disease with high mortality. There are …

C OVID-19 is a complicated disease caused by SARS-CoV-2 (Severe Acute Respiratory
Syndrome Coronavirus-2), which rapidly spread and was announced as a severe pandemic …